160 related articles for article (PubMed ID: 30657933)
1. Somatostatin Receptor Expression Is Associated With Metastasis and Patient Outcome in Pulmonary Carcinoid Tumors.
Vesterinen T; Leijon H; Mustonen H; Remes S; Knuuttila A; Salmenkivi K; Vainio P; Arola J; Haglund C
J Clin Endocrinol Metab; 2019 Jun; 104(6):2083-2093. PubMed ID: 30657933
[TBL] [Abstract][Full Text] [Related]
2. Expression of Somatostatin Receptors 1-5 and Dopamine Receptor 2 in Lung Carcinoids: Implications for a Therapeutic Role.
Kanakis G; Grimelius L; Spathis A; Tringidou R; Rassidakis GZ; Öberg K; Kaltsas G; Tsolakis AV
Neuroendocrinology; 2015; 101(3):211-22. PubMed ID: 25765100
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical somatostatin receptor expression in insulinomas.
Peltola E; Vesterinen T; Leijon H; Hannula P; Huhtala H; Mäkinen M; Nieminen L; Pirinen E; Rönty M; Söderström M; Arola J; Jaatinen P
APMIS; 2023 Apr; 131(4):152-160. PubMed ID: 36680557
[TBL] [Abstract][Full Text] [Related]
4. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.
Kumar U; Sasi R; Suresh S; Patel A; Thangaraju M; Metrakos P; Patel SC; Patel YC
Diabetes; 1999 Jan; 48(1):77-85. PubMed ID: 9892225
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological indicators of survival among patients with pulmonary carcinoid tumor.
Vesterinen T; Mononen S; Salmenkivi K; Mustonen H; Räsänen J; Salo JA; Ilonen I; Knuuttila A; Haglund C; Arola J
Acta Oncol; 2018 Aug; 57(8):1109-1116. PubMed ID: 29463166
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin and dopamine receptor expression in neuroendocrine neoplasms: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores.
Diakatou E; Alexandraki KI; Tsolakis AV; Kontogeorgos G; Chatzellis E; Leonti A; Kaltsas GA
Clin Endocrinol (Oxf); 2015 Sep; 83(3):420-8. PubMed ID: 25808161
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies against the human somatostatin receptor subtypes 1-5: development and immunohistochemical application in neuroendocrine tumors.
Schmid HA; Lambertini C; van Vugt HH; Barzaghi-Rinaudo P; Schäfer J; Hillenbrand R; Sailer AW; Kaufmann M; Nuciforo P
Neuroendocrinology; 2012; 95(3):232-47. PubMed ID: 22156600
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration].
Xie YM; Yan LN; Wei B; Guo MM; Tang CW
Ai Zheng; 2007 Jul; 26(7):688-92. PubMed ID: 17626741
[TBL] [Abstract][Full Text] [Related]
10. Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer.
Qiu CZ; Wang C; Huang ZX; Zhu SZ; Wu YY; Qiu JL
World J Gastroenterol; 2006 Apr; 12(13):2011-5. PubMed ID: 16610049
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor expression in Merkel cell carcinoma: correlation with clinical data.
Fagerstedt KW; Vesterinen T; Leijon H; Sihto H; Böhling T; Arola J
Acta Oncol; 2023 Sep; 62(9):1001-1007. PubMed ID: 37540574
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of somatostatin receptors 1-5 in neuroendocrine carcinoma of the lung.
Tsuta K; Wistuba II; Moran CA
Pathol Res Pract; 2012 Aug; 208(8):470-4. PubMed ID: 22770972
[TBL] [Abstract][Full Text] [Related]
13. Gene expression of somatostatin receptor 4 predicts clinical outcome of patients with metastatic neuroendocrine tumors treated with somatostatin analogs.
Slaby O; Sachlova M; Bednarikova M; Fabian P; Svoboda M; Vytopilova S; Valik D; Vyzula R
Cancer Biother Radiopharm; 2010 Apr; 25(2):237-43. PubMed ID: 20423238
[TBL] [Abstract][Full Text] [Related]
14. Dopamine 2 and somatostatin 1-5 receptors coexpression in clinically non-functioning pituitary adenomas.
Gabalec F; Drastikova M; Cesak T; Netuka D; Masopust V; Machac J; Marek J; Cap J; Beranek M
Physiol Res; 2015; 64(3):369-77. PubMed ID: 25536318
[TBL] [Abstract][Full Text] [Related]
15. Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients.
Muscarella LA; D'Alessandro V; la Torre A; Copetti M; De Cata A; Parrella P; Sperandeo M; Pellegrini F; Frusciante V; Maiello E; Merla G; Fazio VM; Vendemiale G
Cell Oncol (Dordr); 2011 Oct; 34(5):435-41. PubMed ID: 21503779
[TBL] [Abstract][Full Text] [Related]
16. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.
Kubota A; Yamada Y; Kagimoto S; Shimatsu A; Imamura M; Tsuda K; Imura H; Seino S; Seino Y
J Clin Invest; 1994 Mar; 93(3):1321-5. PubMed ID: 8132773
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of nestin and its association with survival in neuroendocrine lung tumours.
Brominska B; Gabryel P; Jarmołowska-Jurczyszyn D; Janicka-Jedyńska M; Trojanowski M; Sawicka-Gutaj N; Czepczyński R; Gut P; Bromiński G; Dyszkiewicz W; Woźniak A; Ruchała M
Pol J Pathol; 2017; 68(4):291-296. PubMed ID: 29517198
[TBL] [Abstract][Full Text] [Related]
18. Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance.
Silva CB; Ongaratti BR; Trott G; Haag T; Ferreira NP; Leães CG; Pereira-Lima JF; Oliveira Mda C
Int J Clin Exp Pathol; 2015; 8(10):13185-92. PubMed ID: 26722517
[TBL] [Abstract][Full Text] [Related]
19. Distribution and functional significance of somatostatin receptors in malignant melanoma.
Lum SS; Fletcher WS; O'Dorisio MS; Nance RW; Pommier RF; Caprara M
World J Surg; 2001 Apr; 25(4):407-12. PubMed ID: 11344389
[TBL] [Abstract][Full Text] [Related]
20. Lung Carcinoids: Long-Term Surgical Results and the Lack of Prognostic Value of Somatostatin Receptors and Other Novel Immunohistochemical Markers.
Daskalakis K; Kaltsas G; Öberg K; Tsolakis AV
Neuroendocrinology; 2018; 107(4):355-365. PubMed ID: 30244255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]